Literature DB >> 23478656

Elevated plasma hemoglobin levels increase nitric oxide consumption in experimental and clinical acute pulmonary thromboembolism.

Jonas T Sertório1, Evandro M Neto-Neves, Carlos A Dias-Junior, Ozélia Sousa-Santos, Tamás Kiss, Diána Mühl, Jose E Tanus-Santos.   

Abstract

OBJECTIVES: We examined whether experimental lung embolization with autologous blood clots or with the infusion of microspheres increase cell-free hemoglobin levels and nitric oxide consumption by plasma samples from anesthetized lambs. These parameters were also measured in patients with acute pulmonary thromboembolism at baseline conditions and after thrombolysis, and in healthy controls.
DESIGN: Controlled animal and clinical studies.
SETTING: University research laboratory and university hospital.
SUBJECTS: Sheep and humans.
INTERVENTIONS: Anesthetized lambs were embolized with intravenous injections of autologous blood clots or repeated injections of 300 μm microspheres. Control animals received saline. Blood samples were drawn from patients with acute pulmonary thromboembolism at baseline conditions and after thrombolytic therapy with streptokinase or alteplase.
MEASUREMENTS AND MAIN RESULTS: Hemodynamic measurements were performed and plasma cell-free hemoglobin concentrations were measured. A nitric oxide consumption assay was used to measure nitric oxide consumption by plasma samples. Embolization with blood clots or microspheres increased mean pulmonary artery pressure from ~15 to ~40 mm Hg in lambs. Both plasma hemoglobin concentrations and nitric oxide consumption increased in proportion to the hemodynamic alterations and correlated significantly. Patients with acute pulmonary thromboembolism had higher plasma hemoglobin concentrations and nitric oxide consumption than healthy controls. Thrombolysis with streptokinase or alteplase further increased both parameters, which peaked 1-3 days after thrombolysis.
CONCLUSIONS: Our results show consistent evidence indicating a new mechanism involving increased hemoglobin decompartmentalization and augmented nitric oxide consumption, possibly contributing to the hemodynamic derangement of acute pulmonary thromboembolism.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23478656     DOI: 10.1097/CCM.0b013e31827c0b43

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  6 in total

Review 1.  Inhaled nitric oxide: role in the pathophysiology of cardio-cerebrovascular and respiratory diseases.

Authors:  Lorenzo Berra; Emanuele Rezoagli; Davide Signori; Aurora Magliocca; Kei Hayashida; Jan A Graw; Rajeev Malhotra; Giacomo Bellani
Journal:  Intensive Care Med Exp       Date:  2022-06-27

2.  Sodium nitrite attenuates MMP-9 production by endothelial cells and may explain similar effects of atorvastatin.

Authors:  Cesar A Meschiari; Lucas C Pinheiro; Danielle A Guimaraes; Raquel F Gerlach; Jose E Tanus-Santos
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2015-11-28       Impact factor: 3.000

3.  Interaction between the Haptoglobin 2 Phenotype and Diabetes Mellitus on Systolic Pulmonary Arterial Pressure and Nitric Oxide Bioavailability in Hemodialysis Patients.

Authors:  Inbal Dahan; Evgeny Farber; Nadia Thauho; Nakhoul Nakhoul; Adi Francis; Mohamad Awawde; Andrew P Levy; Daniel B Kim-Shapiro; Swati Basu; Farid Nakhoul
Journal:  J Diabetes Res       Date:  2015-06-11       Impact factor: 4.011

4.  Treatment with new organic nitrites in pulmonary hypertension of acute experimental pulmonary embolism.

Authors:  Kristofer F Nilsson; Lars E Gustafsson
Journal:  Pharmacol Res Perspect       Date:  2019-01-22

5.  Endogenously released adenosine causes pulmonary vasodilation during the acute phase of pulmonary embolization in dogs.

Authors:  Hiroko Takahama; Hiroshi Asanuma; Osamu Tsukamoto; Shin Ito; Masafumi Kitakaze
Journal:  Int J Cardiol Heart Vasc       Date:  2019-07-10

6.  Matrix metalloproteinase inhibition attenuates right ventricular dysfunction and improves responses to dobutamine during acute pulmonary thromboembolism.

Authors:  Evandro M Neto-Neves; Ozelia Sousa-Santos; Karina C Ferraz; Elen Rizzi; Carla S Ceron; Minna M D Romano; Luis G Gali; Benedito C Maciel; Richard Schulz; Raquel F Gerlach; Jose E Tanus-Santos
Journal:  J Cell Mol Med       Date:  2013-11-06       Impact factor: 5.310

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.